Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Prostate. 2011 Mar 22;71(15):1608–1615. doi: 10.1002/pros.21377

TABLE III.

Description of the Different PSADTs

PSADT (months) PSADT-base PSADT-a PSADT-b PSADT-c
Mean ± SD 9.67 ± 8.57 2.69 ± 2.86 5.1 ± 11.65 5.45 ± 5.14
    (range); median (0.27–53.9); 7.34 (0.49–30.5); 2 (0.84–112.96); 2.54 (1.31–30.5); 3.7

PSADT-base, baseline pre-treatment PSADT; PSADT-a, off treatment PSADT based on all relapsed PSAs; PSADT-b, PSADT based only on relapsed PSA values observed after serum testosterone recovery to ≥150 ng/ml; PSADT-c, PSADT based only on relapsed PSA values observed ≥3 months after testosterone recovery.